Revolutionizing Obesity Treatment through Advanced Fat Cell Engineering.

Mission

MelliCell is dedicated to pioneering transformative obesity treatments through advanced adipose tissue engineering, developing groundbreaking therapeutics that restore fat cells to their healthy state and effectively address the root causes of obesity and related metabolic disorders.

Platform

MelliCell’s proprietary M3 technology enables the controlled growth of adipocytes to different states of obesity, providing a unique and powerful tool for the development and testing of obesity treatments.

About Diabetes

You or someone you know is likely affected by diabetes and you are not alone. In the United States, 1 out of every 11 people. has diabetes. That number is rapidly growing and is projected to be 1 in 3 by 2050. For such a pervasive disease, diabetes is widely misunderstood. Here are some helpful insights about the state of this disease on a global scale.